Online citations, reference lists, and bibliographies.
← Back to Search

The Cognitive Neurology Of Corticobasal Degeneration And Progressive Supranuclear Palsy

C. Fredericks, S. E. Lee
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1093/BRAIN/AWL315
Mixing pro- and antisaccades in patients with parkinsonian syndromes.
S. Rivaud-Pechoux (2007)
10.1093/BRAIN/AWF080
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.
A. Hughes (2002)
10.1007/s00401-007-0237-2
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
N. Cairns (2007)
10.1093/BRAIN/AWM104
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
D. Williams (2007)
10.1016/j.mad.2005.09.013
Clinical and neuropsychological features of corticobasal degeneration
Nataliya Belfor (2006)
10.1002/mds.10488
Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank
K. Josephs (2003)
10.1016/j.jns.2005.05.015
Decreased β-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration
M. Noguchi (2005)
10.1212/WNL.54.5.1029
Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy
S. Rivaud-Pechoux (2000)
10.1093/BRAIN/AWL276
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome.
M. Masellis (2006)
10.1093/brain/awu064
Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
N. Okamura (2014)
10.1093/BRAIN/AWH598
The evolution and pathology of frontotemporal dementia.
A. Kertesz (2005)
10.1136/jnnp.2008.169383
Corticobasal syndrome associated with a novel 1048_1049insG progranulin mutation
J. Rohrer (2009)
10.1007/978-3-7091-6641-3_11
The neuropathology of progressive supranuclear palsy.
P. Lantos (1994)
10.1093/HMG/8.4.711
Association of an extended haplotype in the tau gene with progressive supranuclear palsy.
M. Baker (1999)
10.1007/s004150050173
Increased CSF tau protein in corticobasal degeneration
K. Mitani (1997)
10.1002/mds.22558
Is the pathology of corticobasal syndrome predictable in life?
B. Shelley (2009)
10.1212/WNL.0b013e31827f0fd1
Criteria for the diagnosis of corticobasal degeneration
M. Armstrong (2013)
10.1212/01.wnl.0000259519.78480.c3
Cognitive and motor assessment in autopsy-proven corticobasal degeneration
R. Murray (2007)
10.1212/WNL.48.1.119
Accuracy of the Clinical Diagnosis of Corticobasal Degeneration
I. Litvan (1997)
10.1212/WNL.53.4.795
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration
B. Boeve (1999)
10.1212/WNL.0b013e3181a92bcc
Familial aggregation of parkinsonism in progressive supranuclear palsy
L. D. Kaat (2009)
10.1002/1531-8249(200012)48:6<939::AID-ANA17>3.0.CO;2-1
A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies
M. Grazia Spillantini (2000)
10.1093/brain/awq123
Does corticobasal degeneration exist? A clinicopathological re-evaluation.
H. Ling (2010)
10.1002/mds.10687
Cerebrospinal fluid Aβ42 levels in multiple system atrophy
M. Verbeek (2004)
10.1016/j.neuroimage.2003.09.070
Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration
K. Gröschel (2004)
10.1038/ng.859
Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy
G. Höglinger (2011)
10.1001/archneurol.2011.1021
Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease.
A. Boxer (2012)
10.1212/WNL.47.5.1184
Neuropsychiatric aspects of progressive supranuclear palsy
I. Litvan (1996)
10.1016/S0304-3940(98)00417-0
Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy
Chris Conrad (1998)
10.1016/S0014-4886(03)00024-4
Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
A. Hughes (2003)
10.1212/WNL.40.8.1203
Cortical‐basal ganglionic degeneration
D. Riley (1990)
10.1007/s00401-009-0612-2
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
I. Mackenzie (2009)
10.1001/ARCHNEUR.55.8.1099
Pharmacological therapy in progressive supranuclear palsy.
K. Kompoliti (1998)
10.1212/WNL.38.7.1031
Prevalence and natural history of progressive supranuclear palsy
L. Golbe (1988)
10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V
Overexpression of four‐repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
C. Chambers (1999)
10.1093/BRAIN/AWH488
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
D. Williams (2005)
10.1002/ana.22424
Clinicopathological correlations in corticobasal degeneration
S. E. Lee (2011)
10.1212/WNL.18.4.349
Further observations in progressive supranuclear palsy
N. J. David (1968)
10.1093/BRAIN/AWL078
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.
K. Josephs (2006)
10.1002/mds.10680
Accuracy of clinical diagnosis of progressive supranuclear palsy
Y. Osaki (2004)
10.1212/WNL.56.12.1702
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
H. Houlden (2001)
10.1097/00005072-199906000-00011
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.
O. Bugiani (1999)
10.1136/jnnp.58.2.174
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
B. Pillon (1995)
10.1111/j.1750-3639.2007.00054.x
Progressive Supranuclear Palsy: Pathology and Genetics
D. Dickson (2007)
10.1002/mds.10536
Corticobasal degeneration as a cognitive disorder
N. Graham (2003)
10.1002/mds.22574
Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome
W. Hu (2009)
10.1016/S0140-6736(99)04137-9
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study
A. Schrag (1999)
10.1007/s004010050652
Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy
K. Arima (1997)
10.1093/JNEN/61.11.935
Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
D. Dickson (2002)
10.1016/j.jns.2009.08.036
Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy
A. Kertesz (2010)
10.1016/j.parkreldis.2009.11.013
Symmetric corticobasal degeneration (S-CBD).
A. Hassan (2010)
10.1016/j.neuroimage.2004.06.013
Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease
S. Price (2004)
10.1212/WNL.0b013e318202038c
TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia
J. Rohrer (2010)
10.1002/mds.21124
Neurofilament heavy‐chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes
J. Brettschneider (2006)
10.1136/jnnp.2003.015297
Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy
C. Brenneis (2004)
10.1007/s004010050436
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease
V. Buée-Scherrer (1996)
10.1001/ARCHNEUR.63.1.81
Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
A. Boxer (2006)
10.1007/s004010050891
Astrocytic pathology in progressive supranuclear palsy: significance for neuropathological diagnosis
Hisashi Matsusaka (1998)
10.1016/J.PARKRELDIS.2007.09.006
Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy.
W. Vanvoorst (2008)
10.1212/WNL.53.9.1969
Dementia as the most common presentation of cortical-basal ganglionic degeneration
D. Grimes (1999)
10.1001/ARCHNEUR.1964.00460160003001
PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.
J. Steele (1964)
10.1007/BF00293314
Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations
K. Wakabayashi (2004)
10.1212/WNL.55.9.1368
The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia
A. Kertesz (2000)
10.1002/ANA.410350408
Eye movements in parkinsonian syndromes
M. Vidailhet (1994)
10.1212/WNL.45.8.1477
The neuropsychological pattern of corticobasal degeneration
B. Pillon (1995)
10.1093/BRAIN/118.3.759
The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal.
S. Daniel (1995)
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
I. Grundke-Iqbal (1986)
10.1073/PNAS.73.11.4070
Tubulin requires tau for growth onto microtubule initiating sites.
G. Witman (1976)
10.1016/S0022-510X(00)00480-9
Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy
K. Urakami (2001)
10.1016/j.neurobiolaging.2006.09.019
Voxel-based morphometry in autopsy proven PSP and CBD
K. Josephs (2008)
10.1002/mds.10321
Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
B. Holmberg (2003)
10.1093/BRAIN/AWF109
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
H. Morris (2002)
10.1002/MDS.870040402
Eyelid movement abnormalities in progressive supranuclear palsy
Lawrence I. Golbe (1989)
10.1093/brain/awr179
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.
K. Rascovsky (2011)
10.1007/s004010050911
Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy
T. Komori (1998)
10.1007/BF03161075
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration
I. Litvan (2009)
10.1016/S1353-8020(00)00011-0
The epidemiology of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Nath (2000)
10.1002/ANA.410390314
Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes
K. Rottach (1996)
10.1093/BRAIN/124.7.1438
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.
U. Nath (2001)
10.1212/WNL.49.5.1284
Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990
J. Bower (1997)
10.1002/mds.21698
Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy
D. Williams (2007)
10.1016/0304-3940(84)90217-9
The basal nucleus of Meynert in patients with progressive supranuclear palsy
F. Tagliavini (1984)
10.1002/mds.21970
The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome
G. Rossi (2008)
10.1016/S1353-8020(08)70027-0
The many faces of corticobasal degeneration.
P. Wadia (2007)
10.1212/01.WNL.0000049473.36612.F2
Possible association of the tau H1/H1 genotype with primary progressive aphasia
M-J Sobrido (2003)
10.1001/ARCHNEUR.59.6.935
Association between the extended tau haplotype and frontotemporal dementia.
P. Verpillat (2002)
10.1006/BBRC.1997.6908
Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology.
H. Arai (1997)
[Provisional diagnostic criteria of corticobasal degeneration (CBD) and the survey of patients with CBD in Japan].
M. Morimatsu (2002)
10.1212/WNL.0b013e3181feb2e8
Imaging correlates of pathology in corticobasal syndrome
J. Whitwell (2010)
10.1212/01.WNL.0000052991.70149.68
Clinical features and natural history of progressive supranuclear palsy
U. Nath (2003)
10.1212/01.wnl.0000191307.69661.c3
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP
K. Josephs (2006)
10.1001/ARCHNEUR.1968.00470310034003
Corticodentatonigral degeneration with neuronal achromasia.
J. Rebeiz (1968)
10.1212/WNL.0b013e31821103e6
Classification of primary progressive aphasia and its variants
M. Gorno-Tempini (2011)
10.1097/WCO.0b013e32833be924
Neuropathology of variants of progressive supranuclear palsy.
D. Dickson (2010)
Widespread cytoskeletal pathology characterizes corticobasal degeneration.
M. Feany (1995)
10.1001/archneurol.2009.328
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.
C. Yu (2010)
10.1093/brain/awn047
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease
Siobhan Garbutt (2008)
10.1159/000114320
Pick’s Disease
J. Constantinidis (1974)
10.1212/01.wnl.0000205132.62517.09
New and reliable MRI diagnosis for progressive supranuclear palsy.
H. Oba (2005)
10.1212/WNL.47.1.1
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
I. Litvan (1996)
10.1176/JNP.2007.19.1.77
Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration.
Y. Geda (2007)
10.1016/j.neulet.2004.05.119
The tau H2 haplotype is almost exclusively Caucasian in origin
W. Evans (2004)
10.1212/WNL.36.7.1005
The clinical features and natural history of the Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)
E. Maher (1986)
10.1016/0304-3940(92)90227-X
Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy
M. Nishimura (1992)
10.1212/WNL.46.4.922
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
I. Litvan (1996)
10.1212/01.wnl.0000267643.24870.26
Frontal presentation in progressive supranuclear palsy
L. D. Kaat (2007)
10.1136/jnnp.64.2.184
Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination
G. Wenning (1998)
10.1148/RADIOL.2453061703
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
A. Quattrone (2008)



Semantic Scholar Logo Some data provided by SemanticScholar